NMRA
NASDAQ · Pharmaceuticals
Neumora Therapeutics Inc
$0.50
+0.02 (+3.35%)
Open$0.57
Previous Close$0.49
Day High$0.57
Day Low$0.47
52W High$3.65
52W Low$0.32
Volume—
Avg Volume2.20M
Market Cap91.51M
P/E Ratio—
EPS$-1.23
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+3,345.3% upside
Current
$0.50
$0.50
Target
$17.34
$17.34
$11.85
$17.34 avg
$21.76
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 131.86M | 126.94M | 118.45M |
| Net Income | 20.35M | 17.55M | 19.05M |
| Profit Margin | 15.4% | 13.8% | 16.1% |
| EBITDA | 29.65M | 29.50M | 31.41M |
| Free Cash Flow | 15.46M | 12.66M | 10.19M |
| Rev Growth | -7.9% | +5.6% | -2.9% |
| Debt/Equity | 0.29 | 0.31 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,403.15 | +3.63% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $281.29 | +1.84% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $147.81 | +0.74% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.47 | +0.27% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $82.35 | +3.72% | 12.8 | 33.59B |